The study, published in Aging Cell, focused on gut luminal exosomes, microscopic particles that cells use to communicate by carrying proteins and genetic material throughout the body. Scientists discovered that exosomes taken from older animals contained molecular signals tied to insulin resistance, inflammation, and damage to the gut barrier. When those exosomes were transferred into young animals, the younger animals developed similar metabolic and inflammatory changes.

Researchers also observed the opposite effect. Exosomes collected from young animals and transferred into older animals reduced several aging-related metabolic problems. The results suggest that the gut environment itself may play an important role in the development of diseases associated with aging.

Gut Barrier Damage and Chronic Inflammation

The study indicates that gut exosomes could directly influence disease development. A weakened gut barrier can allow inflammatory substances to leak into the bloodstream, potentially triggering long-term inflammation and raising the risk of heart disease and metabolic disorders.

“This study helps clarify how the physiological stressors associated with biological aging may accelerate biological processes linked to aging and disease,” said Abdelnaby Khalyfa, M.Sc., Ph.D., professor of biomedical sciences at the Joan C. Edwards School of Medicine and lead author on the study. “Understanding these mechanisms is essential to identifying new targets for intervention and improving long-term outcomes for patients.”

New Clues About Aging and Disease

The findings also reinforce the idea that aging affects multiple systems in the body at the same time, including metabolism, immune responses, and cellular communication pathways. Researchers identified specific molecules inside the exosomes that may eventually help scientists detect, better understand, and possibly treat age-related diseases.

The researchers noted that the findings may also apply to chronic conditions involving long-term physiological stress, particularly diseases that share biological pathways with aging.

The research team included Khalyfa, Trupti Joshi, Ph.D., and David Gozal, M.D., M.B.A., Ph.D. (Hon) from Marshall University, along with Lyu Zhen from the University of Missouri.

Funding for the study included unrestricted start-up support awarded to Khalyfa by the Joan C. Edwards School of Medicine through the Marshall University Research Corporation (MURC), Huntington, West Virginia, USA. Gozal also received partial support from NIH grants HL166617 and HL169266. Additional support came from the National Institute of General Medical Sciences of the National Institutes of Health under Award Number P20GM103434 through the West Virginia IDeA Network of Biomedical Research Excellence (WV-INBRE).